MetLife (MET) is back in focus after two separate developments: an expanded bereavement support partnership in Ireland and the completion of a mixed use real estate project in Tampa, which have prompted fresh interest in the stock.

Against this backdrop, MetLife’s share price has moved to $92.54, with a 30 day share price return of 5.12% and a 90 day share price return of 19.10%, while the 1 year total shareholder return of 22.53% and 5 year total shareholder return of 85.06% point to momentum that has built over time rather than faded.

If MetLife’s recent news has you thinking about financials more broadly, it could be a good moment to widen your search and check out 17 top founder-led companies.

MetLife’s mix of global insurance, benefits and real estate investments looks solid on paper, and the share price has clearly reacted. The next step is simple: is that quality already fully reflected in today’s valuation?

Most Popular Narrative: 3% Undervalued

On the numbers, MetLife’s most followed narrative pegs fair value at $95.31, a little above the last close of $92.54. This puts the spotlight on the assumptions behind that gap.

Strategic expansion of asset-light, fee-generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital-intensive earnings growth.

Want to see what is driving that valuation edge for MetLife? The narrative leans on steadier revenue growth, rising margins and a different earnings mix than the past. The detailed projections are where the story really gets interesting.

Result: Fair Value of $95.31 (UNDERVALUED)

However, the MetLife story can change quickly if commercial mortgage loan losses deepen, or if slower digital progress leaves the company exposed to more agile competitors.

Another View on MetLife’s Valuation

The headline narrative describes MetLife as modestly undervalued, with fair value close to $95. That sits awkwardly beside Simply Wall St’s DCF output, which places the value of future cash flows at $170.75 per share, or around 46% above the current $92.54 price. Which signal should carry more weight for you?

Before leaning on any one approach, it can help to understand how the SWS DCF model arrives at its view and which assumptions you find realistic for MetLife’s future cash flows. Look into how the SWS DCF model arrives at its fair value.

Next Steps

If the mix of optimism and caution around MetLife resonates with you, consider reviewing the data now and evaluating both sides through the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond MetLife?

If MetLife has sharpened your appetite for opportunity, do not stop here. Fresh ideas across sectors can help balance risk and reveal potential you might otherwise miss.

• Spot potential turnaround stories early by reviewing 21 elite penny stocks with strong financials that already show stronger financial foundations than typical micro caps.
• Target quality at a reasonable price by scanning the 38 high quality undervalued stocks that pair healthy cash flows with what may be undemanding valuations.
• Prioritize resilience and sleep easier at night by focusing on the 79 resilient stocks with low risk scores that score well on financial strength and risk metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.